Selected research
Industry Research
Paricalcitol Industry Research Report 2026
Market perspective
The global Paricalcitol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Paricalcitol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Paricalcitol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Paricalcitol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Paricalcitol include Teva Pharmaceutical Industries Ltd, Neuland Laboratories Inc, Chongqing Huapont Pharmaceutical Co. Ltd, Haoyuan Chemexpress Co.Ltd, Rochem International, Inc, DISHMAN NETHERLANDS B.V., ChemWerth Inc and ALP Pharm Beijing Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Paricalcitol market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Paricalcitol Market by Company
Teva Pharmaceutical Industries Ltd
Neuland Laboratories Inc
Chongqing Huapont Pharmaceutical Co. Ltd
Haoyuan Chemexpress Co.Ltd
Rochem International, Inc
DISHMAN NETHERLANDS B.V.
ChemWerth Inc
ALP Pharm Beijing Co., Ltd
Paricalcitol Segment by Type
Purity, ≥99%
Purity, ≥98%
Others
Paricalcitol Segment by Application
Injection Product
Capsule Product
Paricalcitol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paricalcitol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paricalcitol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paricalcitol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Paricalcitol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Paricalcitol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Paricalcitol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity, ≥99%
- Purity, ≥98%
- Others
Applications
- Injection Product
- Capsule Product
Companies covered
- Teva Pharmaceutical Industries Ltd
- Neuland Laboratories Inc
- Chongqing Huapont Pharmaceutical Co. Ltd
- Haoyuan Chemexpress Co.Ltd
- Rochem International, Inc
- DISHMAN NETHERLANDS B.V.
- ChemWerth Inc
- ALP Pharm Beijing Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Paricalcitol Market Size (2021-2032)
- 2.2.2 Global Paricalcitol Sales (2021-2032)
- 2.2.3 Global Paricalcitol Market Average Price (2021-2032)
- 2.3 Paricalcitol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity, ≥99%
- 2.3.3 Purity, ≥98%
- 2.3.4 Others
- 2.4 Paricalcitol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection Product
- 2.4.3 Capsule Product
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Paricalcitol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Paricalcitol Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Paricalcitol Revenue of Manufacturers (2021-2026)
- 3.4 Global Paricalcitol Average Price by Manufacturers (2021-2026)
- 3.5 Global Paricalcitol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Paricalcitol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Paricalcitol, Product Type & Application
- 3.8 Global Manufacturers of Paricalcitol, Established Date
- 3.9 Global Paricalcitol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries Ltd
- 4.1.1 Teva Pharmaceutical Industries Ltd Company Information
- 4.1.2 Teva Pharmaceutical Industries Ltd Business Overview
- 4.1.3 Teva Pharmaceutical Industries Ltd Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Ltd Paricalcitol Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.2 Neuland Laboratories Inc
- 4.2.1 Neuland Laboratories Inc Company Information
- 4.2.2 Neuland Laboratories Inc Business Overview
- 4.2.3 Neuland Laboratories Inc Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Neuland Laboratories Inc Paricalcitol Product Portfolio
- 4.2.5 Neuland Laboratories Inc Recent Developments
- 4.3 Chongqing Huapont Pharmaceutical Co. Ltd
- 4.3.1 Chongqing Huapont Pharmaceutical Co. Ltd Company Information
- 4.3.2 Chongqing Huapont Pharmaceutical Co. Ltd Business Overview
- 4.3.3 Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chongqing Huapont Pharmaceutical Co. Ltd Paricalcitol Product Portfolio
- 4.3.5 Chongqing Huapont Pharmaceutical Co. Ltd Recent Developments
- 4.4 Haoyuan Chemexpress Co.Ltd
- 4.4.1 Haoyuan Chemexpress Co.Ltd Company Information
- 4.4.2 Haoyuan Chemexpress Co.Ltd Business Overview
- 4.4.3 Haoyuan Chemexpress Co.Ltd Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Haoyuan Chemexpress Co.Ltd Paricalcitol Product Portfolio
- 4.4.5 Haoyuan Chemexpress Co.Ltd Recent Developments
- 4.5 Rochem International, Inc
- 4.5.1 Rochem International, Inc Company Information
- 4.5.2 Rochem International, Inc Business Overview
- 4.5.3 Rochem International, Inc Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Rochem International, Inc Paricalcitol Product Portfolio
- 4.5.5 Rochem International, Inc Recent Developments
- 4.6 DISHMAN NETHERLANDS B.V.
- 4.6.1 DISHMAN NETHERLANDS B.V. Company Information
- 4.6.2 DISHMAN NETHERLANDS B.V. Business Overview
- 4.6.3 DISHMAN NETHERLANDS B.V. Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 DISHMAN NETHERLANDS B.V. Paricalcitol Product Portfolio
- 4.6.5 DISHMAN NETHERLANDS B.V. Recent Developments
- 4.7 ChemWerth Inc
- 4.7.1 ChemWerth Inc Company Information
- 4.7.2 ChemWerth Inc Business Overview
- 4.7.3 ChemWerth Inc Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ChemWerth Inc Paricalcitol Product Portfolio
- 4.7.5 ChemWerth Inc Recent Developments
- 4.8 ALP Pharm Beijing Co., Ltd
- 4.8.1 ALP Pharm Beijing Co., Ltd Company Information
- 4.8.2 ALP Pharm Beijing Co., Ltd Business Overview
- 4.8.3 ALP Pharm Beijing Co., Ltd Paricalcitol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ALP Pharm Beijing Co., Ltd Paricalcitol Product Portfolio
- 4.8.5 ALP Pharm Beijing Co., Ltd Recent Developments
5 Global Paricalcitol Market Scenario by Region
- 5.1 Global Paricalcitol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Paricalcitol Sales by Region: 2021-2032
- 5.2.1 Global Paricalcitol Sales by Region: 2021-2026
- 5.2.2 Global Paricalcitol Sales by Region: 2027-2032
- 5.3 Global Paricalcitol Revenue by Region: 2021-2032
- 5.3.1 Global Paricalcitol Revenue by Region: 2021-2026
- 5.3.2 Global Paricalcitol Revenue by Region: 2027-2032
- 5.4 North America Paricalcitol Market Facts & Figures by Country
- 5.4.1 North America Paricalcitol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Paricalcitol Sales by Country (2021-2032)
- 5.4.3 North America Paricalcitol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Paricalcitol Market Facts & Figures by Country
- 5.5.1 Europe Paricalcitol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Paricalcitol Sales by Country (2021-2032)
- 5.5.3 Europe Paricalcitol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Paricalcitol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Paricalcitol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Paricalcitol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Paricalcitol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Paricalcitol Market Facts & Figures by Country
- 5.7.1 South America Paricalcitol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Paricalcitol Sales by Country (2021-2032)
- 5.7.3 South America Paricalcitol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Paricalcitol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Paricalcitol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Paricalcitol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Paricalcitol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Paricalcitol Sales by Type (2021-2032)
- 6.1.1 Global Paricalcitol Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Paricalcitol Sales Market Share by Type (2021-2032)
- 6.2 Global Paricalcitol Revenue by Type (2021-2032)
- 6.2.1 Global Paricalcitol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Paricalcitol Revenue Market Share by Type (2021-2032)
- 6.3 Global Paricalcitol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Paricalcitol Sales by Application (2021-2032)
- 7.1.1 Global Paricalcitol Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Paricalcitol Sales Market Share by Application (2021-2032)
- 7.2 Global Paricalcitol Revenue by Application (2021-2032)
- 7.2.1 Global Paricalcitol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Paricalcitol Revenue Market Share by Application (2021-2032)
- 7.3 Global Paricalcitol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Paricalcitol Value Chain Analysis
- 8.1.1 Paricalcitol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Paricalcitol Production Mode & Process
- 8.2 Paricalcitol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Paricalcitol Distributors
- 8.2.3 Paricalcitol Customers
9 Global Paricalcitol Analyzing Market Dynamics
- 9.1 Paricalcitol Industry Trends
- 9.2 Paricalcitol Industry Drivers
- 9.3 Paricalcitol Industry Opportunities and Challenges
- 9.4 Paricalcitol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst